Publications - 'O'
Publications 1026 - 1050 de 1113
| Titre | DOI |
|---|---|
|
Ovarian cancer: Early relapse P. Pautier; E. Kalbacher; T.De la Mott Rouge; F. Bonnetain; A. Lesoin 2017 |
10.1016/S0007-4551(17)30160-1 |
|
Ovarian function recovery in newly diagnosed advanced Hodgkin lymphoma patients treated with PET-adapted regimen: prospective analysis of a mu Iticentric randomized phase 3 trial (AHL2011) I. Demeestere; J. Dechene; J. Racape; R. Bouabdallah; P. Brice; H. Ghesquieres; A. Stamatoulas; J. Dupuisl; A.G. Gac; T. Gastinne; B. Joly'; K. Bouabdallah; 2020 |
|
|
Ovarian function recovery in newly diagnosed advanced Hodgkin lymphoma patients treated with PET-adapted regimen: prospective analysis of a mu Iticentric randomized phase 3 trial (AHL2011) I. Demeestere; J. Dechene; J. Racape; R. Bouabdallah; P. Brice; H. Ghesquieres; A. Stamatoulas; J. Dupuisl; A.G. Gac; T. Gastinne; B. Joly'; K. Bouabdallah; 2020 |
|
|
Ovarian metastasis of a malignant melanoma: A case report A. Mendel; J.J. Terzibachian; F. Aubin; L. Malicenco; R. Ramanah; D. Riethmuller 2017 |
10.1016/j.jogoh.2017.02.016 |
|
Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells D. Crabtree; M. Dodson; X. Ouyang; M. Boyer-Guittaut; Q. Liang; M.E. Ballestas; N. Fineberg; J. Zhang 2014 |
10.1111/jnc.12497 |
|
Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults C.C. Chang; A.C. Cheng; A.B. Chang 2014 |
10.1002/14651858.CD006088.pub4 |
|
Overactivation of the endocannabinoid system alters the antilipolytic action of insulin in mouse adipose tissue T. Muller; L. Demizieux; S. Troy-Fioramonti; J. Gresti; J.P.Pais de Barros; H. Berger; B. Verges; P. Degrace 2017 |
10.1152/ajpendo.00374.2016 |
|
Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine-based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Dur A.F. Sobrero; T. Andre; J.A. Meyerhardt; A. Grothey; T. Iveson; T. Yoshino; I. Sougklakos; J.P. Meyers; R. Labianca; M.P. Saunders; D. Vernerey; T. Yamanaka; I. Boukovinas; E. Oki; V. Georgoulias; V. Torri; A. Harkin; J. Taieb; A.Frank Shields; Q. Shi 2020 |
|
|
Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin and fluoropyrimidine-based therapy for patients (pts) with stage III colon cancer (CC): Final results from the IDEA (International Dur A.F. Sobrero; T. Andre; J.A. Meyerhardt; A. Grothey; T. Iveson; T. Yoshino; I. Sougklakos; J.P. Meyers; R. Labianca; M.P. Saunders; D. Vernerey; T. Yamanaka; I. Boukovinas; E. Oki; V. Georgoulias; V. Torri; A. Harkin; J. Taieb; A.Frank Shields; Q. Shi 2020 |
|
|
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR B. Reix; J.C. Bernhard; J.J. Patard; P. Bigot; A. Villers; E. Suer; N.S. Vuong; G. Verhoest; Q. Alimi; J.B. Beauval; T. Benoit; F.X. Nouhaud; C. Lenormand; N. Hamidi; J. Cai; M. Eto; S. Larre; E. Bakhri; G. Ploussard; A. Hung; N. Koutlidis; A. Schneider; J. Carrouget; S. Droupy; S. Marchal; A. Doerfler; S. Seddik; T. Matsugasumi; X. Orsoni; A. Descazeaud; C. Pfister; K. Bensalah; M. Soulie; I. Gill; V. Flamand; K.Canc Grp CCAFU 2018 |
10.1016/j.purol.2017.12.004 |
|
OVERALL SURVIVAL IMPACT OF BEACOPP VERSUS ABVD IN ADVANCED HODGKIN LYMPHOMA: A POOLED ANALYSIS OF 4 RANDOMIZED TRIALS M. Andre; C. Fortpied; S. Viviani; M. Bellei; P. Carde; M. Hutchings; A. Gianni; P. Brice; O. Casasnovas; P. Gobbi; P.L. Zinzani; J. Dupuis; E. Iannitto; A. Rambaldi; J. Briere; A. Perrot; M. Heczko; P. Valagussa; J. Douxfils; C. Joubert; M. Federico; N. Mounier 2016 |
|
|
Overall survival of patients with HER2-negative metastatic breast cancer treated with a first-line paclitaxel with or without bevacizumab in real-life setting: Results of a multicenter national observational study. S. Delaloge; D. Perol; E. Brain; B. Asselain; T.Denis Bachelo; M. Debled; V. Dieras; M. Campone; C. Levy; W. Jacot; V. Lorgis; C. Veyret; F. Dalenc; J.M. Ferrero; L. Uwer; A. Goncalves; I. Piot; G. Simon; M. Robain; C. Cailliot 2016 |
10.1200/JCO.2016.34.15_suppl.1013 |
|
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma A. Vienot; G. Beinse; C. Louvet; L. de Mestier; A. Meurisse; F. Fein; B. Heyd; D. Cleau; C. d'Engremont; A.C. Dupont-Gossart; Z. Lakkis; C. Tournigand; O. Bouche; B. Rousseau; C. Neuzillet; F. Bonnetain; C. Borg; D. Vernerey 2017 |
10.1093/jnci/djx037 |
|
Overcoming limitations of nanomechanical resonators with simultaneous resonances N. Kacem; S. Baguet; L. Duraffourg; G. Jourdan; R. Dufour; S. Hentz 2015 |
10.1063/1.4928711 |
|
Overcoming resistance to product rebranding V. Collange; A. Bonache 2015 |
10.1108/JPBM-10-2014-0730 |
|
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch W. Warda; M.Neto Da Rocha; R. Trad; R. Haderbache; Y. Salma; L. Bouquet; X. Roussel; C. Nicod; M. Deschamps; C. Ferrand Submitted |
10.1038/s41417-020-00284-3, Early Access Date = {JAN 2021 |
|
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch W. Warda; M.Neto Da Rocha; R. Trad; R. Haderbache; Y. Salma; L. Bouquet; X. Roussel; C. Nicod; M. Deschamps; C. Ferrand 2021 |
10.1038/s41417-020-00284-3 |
|
Overcrowding in the Emergency Department: Could a Patient-centred Mobile App Change This Paradigm? I. Margarido; N.Kasonga Alpha; N. Junior; J. Marin 2020 |
10.5220/0009365303630367 |
|
Overdiagnosis of thyroid cancer in the Marne and Ardennes Departments of France from 1975 to 2014 C. Saint-Martina; M. Drame; S. Dabakuyo; L. Kanagaratnam; P. Arveux; C. Schvartz 2017 |
10.1016/j.ando.2016.07.005 |
|
Overestimation of the strength of size-assortative pairing in taxa with cryptic diversity: a case of Simpson's paradox M. Galipaud; L. Bollache; R. Wattier; C. Dubreuil; F.X. Dechaume-Moncharmont; C. Lagrue 2015 |
10.1016/j.anbehav.2015.01.032 |
|
Overexpression of genes involved in the epigenetic mechanisms supressing the transcription in the cerebral cortex and the blood leukocytes of depressive patients R. Rey; S. Ragot; J.C. Chauvet-Gelinier; B. Bonin; J.R. Teyssier 2015 |
10.1016/j.eurpsy.2015.09.227 |
|
Overlapping community detection versus ground-truth in AMAZON co-purchasing network M. Jebabli; H. Cherifi; C. Cherifi; A. Hamouda 2015 |
10.1109/SITIS.2015.47 |
|
Overlapping Community Structure in Co-authorship Networks: a Case Study M. Jebabli; H. Cherifi; C. Cherifi; A. Hamouda 2014 |
10.1109/UNESST.2014.11 |
|
Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants E. Ranza; A. Guimier; A. Verloes; Y. Capri; C. Marques; M. Auclair; M. Mathieu-Dramard; G. Morin; J. Thevenon; L. Faivre; C. Thauvin-Robinet; M. Innes; D.A. Dyment; C. Vigouroux; J. Amiel 2020 |
10.1111/cge.13746, Early Access Date = {APR 2020 |
|
Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants E. Ranza; A. Guimier; A. Verloes; Y. Capri; C. Marques; M. Auclair; M. Mathieu-Dramard; G. Morin; J. Thevenon; L. Faivre; C. Thauvin-Robinet; M. Innes; D.A. Dyment; C. Vigouroux; J. Amiel 2020 |
10.1111/cge.13746 |